Myriad Genetics MYGN EBIT
EBIT at other companies
Other financials
Where this comes from
Calculated from Myriad Genetics’s reported figures.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's EBIT?
- Myriad Genetics (MYGN) reported EBIT of -$30.7M in Q1 2026.
- How has Myriad Genetics's EBIT changed year-over-year?
- Myriad Genetics's EBIT decreased by 5.9% year-over-year, from -$29M to -$30.7M.
- What is the long-term trend for Myriad Genetics's EBIT?
- Over 4 years (2021 to 2025), Myriad Genetics's EBIT has grown at a 19.4% compound annual growth rate (CAGR), from -$190.5M to -$387.2M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.